OPTIMIZATION OF RECOMBINANT ANTIBODY PRODUCTION IN CHO CELLS

The optimization of recombinant antibody production within Chinese hamster ovary (CHO) cells remains a paramount challenge for the biopharmaceutical industry. A variety of strategies can be employed to antibody titer, such as process parameter optimization, genetic engineering, and adoption of perfusion technologies. Fine-tuning media composition